COVID-19 mortality across selected states in India: the role of age structure

Mohamed Jainul Azarudeen; Khyati Aroskar; Karishma Krishna Kurup; Tanzin Dikid; Himanshu Chauhan; S.K. Jain; S.K. Singh

doi:10.1101/2021.07.18.21259093

Abstract

Background Mortality rates provide an opportunity to identify and act on the health system intervention for preventing deaths. Hence, it is essential to appreciate the influence of age structure while reporting mortality for a better summary of the magnitude of the epidemic.

Objectives We described and compared the pattern of COVID-19 mortality standardized by age between selected states and India from January to November 2020.

Methods We initially estimated the Indian population for 2020 using the decadal growth rate from the previous census (2011). This was followed by estimations of crude and age-adjusted mortality rate per million for India and the selected states. We used this information to perform indirect standardization and derive the age-standardized mortality rates for the states for comparison. In addition, we derived a ratio for age-standardized mortality to compare across age groups within the state. We extracted information regarding COVID-19 deaths from the Integrated Disease Surveillance Programme special surveillance portal up to November 16, 2020.

Results The crude mortality rate of India stands at 88.9 per million population(118,883/1,337,328,910). Age-adjusted mortality rate (per million) was highest for Delhi (300.5) and lowest for Kerala (35.9).The age-standardized mortality rate (per million) for India is (<15 years=1.6, 15–29 years=6.3, 30–44 years=35.9, 45– 59 years=198.8, 60–74 years=571.2, ≥75 years=931.6). The ratios for age-standardized mortality increase proportionately from 45-59 years age group across all the states.

Conclusion There is high COVID-19 mortality not only among the elderly ages, but we also identified heavy impact of COVID-19 on the working population. Therefore, we recommend further evaluation of age-adjusted mortality for all States and inclusion of variables like gender, socio-economic status for standardization while identifying at-risk populations and implementing priority public health actions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding support was received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study examined aggregate secondary data from COVID 19 web-based portal on death outcomes and age for selected states in the study period. This study protocol was approved by the public health emergency operational research review board of National Centre for Disease Control to initiate this analysis. Names and identifiers were delinked for confidentiality, and only an anonymized dataset was provided to the group on select variables for analysis.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes